⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Bajaj Finserv Healthcare Fund - Regular Plan - IDCW | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Bajaj Finserv MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.52 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Sorbh Gupta | Nikhil Mathur |
| Inception | 27 Dec 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 15.16% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 7.19% | 29.15% |
| Risk | ||
| 14.65 | 14.07 | |
| 0.63 | 0.59 | |
| 0.32 | 1.59 | |
| 8.17 | 21.67 | |
| 0.59 | 3.48 | |
| -9.41% | -9.23% | |
| Costs | ||
| Expense Ratio | 2.59% | 1.03% |
| Exit Load | 1% on or before 3M, Nil after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹500 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Bajaj Finserv…61%
HDFC MF61%
39.1%Only 39.1% of holdings by weight are common between Bajaj Finserv MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingBajaj Finserv MFHDFC MF
Divi's Laboratories Ltd.9.75%9.39%
Sun Pharmaceutical Industries Ltd.8.96%8.28%
Apollo Hospitals Enterprise Ltd.5.51%3.69%
Torrent Pharmaceuticals Ltd.4.78%3.65%
Neuland Laboratories Ltd.3.82%3.24%
Max Healthcare Institute Ltd.2.99%3.61%
Alkem Laboratories Ltd.2.96%4.64%
Rubicon Research Ltd.6.08%2.52%
Ipca Laboratories Ltd.2.40%2.98%
Category context: Equity vs Equity. Open the full Screener →